DMTP in urine: making sense of a pesticide exposure marker
Clinical review pending
DMTP can indicate recent contact with certain pesticides or their breakdown products. Here is why timing, urine dilution and exposure history matter.

Dimethylthiophosphate, or DMTP, is measured in urine as a clue to recent uptake of certain organophosphate-related substances. The result can help investigate pesticide contact. It cannot tell you which individual product was involved or whether a health effect has occurred.
What DMTP reveals about recent contact
DMTP belongs to a group called dialkyl phosphate metabolites. It can form when the body breaks down certain dimethyl organophosphate insecticides. These products are, or have been, used in agriculture and some pest-control applications. Which products matter depends on their active ingredients and local approvals.
Exposure can occur through food, inhaled particles or vapors, and skin contact. Breakdown products that formed outside the body can also be absorbed. Urinary DMTP therefore does not correspond to a known quantity of active pesticide.
Laboratories often measure DMTP alongside related metabolites in a urine sample. Results may be reported as a concentration or adjusted for urinary creatinine. That adjustment accounts for some of the variation caused by differences in urine dilution.
The sampling window is short. It usually concerns the preceding day or two, or the immediately preceding days depending on exposure and collection conditions. This is not a guaranteed detection window, and a single sample does not represent lifetime exposure.
Why researchers study this marker
Organophosphates can inhibit an enzyme called acetylcholinesterase. It helps end nerve signals by breaking down the signaling chemical acetylcholine. A high exposure can consequently cause acute, sometimes severe, poisoning.
At lower, recurring exposures, researchers investigate possible links with neurological development and behavior. Some population studies find associations, although findings are not uniform. One prenatal cohort linked higher maternal urinary DAP concentrations with lower childhood cognitive scores. It studied a metabolite group, not DMTP alone. Such associations cannot establish the cause of an individual’s symptoms or determine their long-term risk from a single DMTP measurement.
The body processes many of these compounds relatively quickly and excretes metabolites in urine. That distinguishes them from substances that can remain in the body for long periods. Repeated contact can nevertheless produce repeatedly elevated measurements. That pattern describes ongoing uptake, not automatically a growing stored reserve.
DMTP also does not measure acetylcholinesterase inhibition. Its concentration cannot directly establish whether the nervous system is affected. Headaches, difficulty concentrating and fatigue are too nonspecific to do so on their own either.
When measuring DMTP may help
The clearest use is a specific exposure question. Examples include handling relevant insecticides at work, repeatedly working in treated areas, or a documented contact followed by symptoms. Product information and the timing of the event help determine which test is appropriate.
An occupational health assessment may help people working in agriculture, landscaping or pest control. It can also establish whether a more specific marker or a workplace investigation would be more informative.
Pregnant people and families with young children should reduce avoidable pesticide contact. That precaution is not the same as recommending routine DMTP screening for everyone. A single low result guarantees neither consistently low exposure nor a particular developmental outcome. Conversely, a high result does not diagnose a condition in a child or pregnancy.
Testing may also be useful after improved protective measures, provided the goal and comparison conditions are defined beforehand. DMTP is not a stand-alone health measure for optimizing fertility, thyroid function or “detoxification capacity.”
Reading the laboratory report
Many laboratory ranges come from population data. They show concentrations found in a particular group and are not automatically health-based limits. An unusual result should prompt a focused question rather than a premature diagnosis.
A low value may fit with little recent uptake. It may also occur because the sample was collected after the relevant window. It does not establish normal nerve function and does not cover every pesticide.
A higher value may suggest greater recent contact with relevant parent substances or preformed breakdown products. Possible sources include particular work processes, treated plants or food. The number identifies neither the exact product nor the absorbed active dose. Slower elimination or organ damage cannot simply be inferred from it either.
Records covering the preceding 24–72 hours can help: activities, products used, locations and collection time. Keep conditions as comparable as possible for repeated measurements. A change after one meal means something different from a recurring pattern after the same task.
Other organophosphate metabolites may add context when they fit the exposure question. General liver, kidney, heavy-metal or “oxidative stress” panels are not automatically necessary for every unusual DMTP result. Additional tests should answer a specific medical question.
If substantial acute symptoms follow known pesticide contact, medical assessment should not wait for a DMTP result. Exposure history, clinical signs and, where appropriate, targeted functional tests take priority.
Frequently asked questions
What is a DMTP test?
It measures dimethylthiophosphate in urine. This marker can indicate recent uptake of certain dimethyl organophosphates or their pre-existing breakdown products. It cannot be assigned unambiguously to one pesticide.
Should I get tested?
The test may help when there is a reasonable suspicion of a relevant exposure. First establish which substance could be involved and when contact occurred. A nonspecific health goal alone does not make a measurement informative.
How often should I measure DMTP?
There is no universal interval. Repeat samples may help during ongoing exposure or when assessing improved protective measures. A routine schedule of every three to twelve months does not automatically suit a marker that mainly describes the preceding days.
What changes the result?
Time since exposure, changing contacts, preformed metabolites and urine dilution are important influences. Collection, storage and laboratory methods also count. One result is not enough to reliably assess individual differences in metabolism.
How should I prepare?
Fasting is usually unnecessary. Depending on the laboratory, a morning urine sample or a sample collected at a specific time may be appropriate. Follow its instructions, drink as usual and record relevant contacts. After known exposure, do not delay assessment to achieve a lower result first. Do not deliberately expose yourself for the test either.
How reliable is it?
Mass spectrometry can measure the DMTP molecule sensitively and specifically. The clinical meaning remains limited: an exact DMTP value is not an exact measurement of the parent pesticide, long-term exposure or a toxic effect.
What does a result outside the reference range mean?
It is a reason to look for recent sources and check collection conditions. Depending on the result and symptoms, a targeted repeat test, protective measures or medical assessment may follow. It does not automatically imply a diagnosis or a need for “detox” treatment.
What is the best way to interpret my result?
Consider the value, units, laboratory range and any creatinine adjustment alongside your exposure history. Product details, timing and specific symptoms help determine the next step. The aim is a clear, practical reduction in relevant contacts, rather than optimizing a laboratory number in isolation.
Sources
- Costa LG (2006). Current issues in organophosphate toxicology. Clinica Chimica Acta, 366(1-2), 1-13. https://doi.org/10.1016/j.cca.2005.10.008 — PubMed
- Barr DB, Wong LY, Bravo R, Weerasekera G, Odetokun M, Restrepo P, Kim DG, Fernandez C, Whitehead RD, Perez J, Gallegos M, Williams BL, Needham LL (2011). Urinary concentrations of dialkylphosphate metabolites of organophosphorus pesticides: National Health and Nutrition Examination Survey 1999-2004. International Journal of Environmental Research and Public Health, 8(8), 3063-3098. https://doi.org/10.3390/ijerph8083063 — PubMed
- Chen L, Zhao T, Pan C, Ross JH, Krieger RI (2012). Preformed biomarkers including dialkylphosphates (DAPs) in produce may confound biomonitoring in pesticide exposure and risk assessment. Journal of Agricultural and Food Chemistry, 60(36), 9342-9351. https://doi.org/10.1021/jf303116p — PubMed
- Bouchard MF, Chevrier J, Harley KG, Kogut K, Vedar M, Calderon N, Trujillo C, Johnson C, Bradman A, Barr DB, Eskenazi B (2011). Prenatal exposure to organophosphate pesticides and IQ in 7-year-old children. Environmental Health Perspectives, 119(8), 1189-1195. https://doi.org/10.1289/ehp.1003185 — PubMed
- Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL (2005). Urinary creatinine concentrations in the U.S. population: Implications for urinary biologic monitoring measurements. Environmental Health Perspectives, 113(2), 192-200. https://doi.org/10.1289/ehp.7337 — PubMed